Zobrazeno 1 - 10
of 45
pro vyhledávání: '"L. Zanitzer"'
Publikováno v:
Urologia Journal. 58:397-400
Publikováno v:
Urologia Journal. 58:263-266
Autor:
M Di Pasquale, B. Campo, G. Gazzano, Carlo Patriarca, Paolo Giunta, F Bergamaschi, L. Zanitzer, P. Corrada, G Ordesi
Publikováno v:
Prostate cancer and prostatic diseases. 9(3)
Radiofrequency interstitial tumor ablation (RITA) is a thermal ablation method that uses needles and low radiofrequency (RF) energy. The aim of our study was to evaluate the histopathology of thermal lesions induced by RF energy delivered interstitia
Autor:
P, Corrada, T, Torelli, G, Ordesi, F, Bergamaschi, L, Zanitzer, C, Santagati, M, Remotti, B, Campo
Publikováno v:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 68(5)
A comparative study between modified Camey II and Studer ileal orthotopic neobladder was performed. The Camey II was modified as follows: 1) The ureters were implanted, using wallace technique, in an undetubularized ileal loop, 15-18 cm. long, to pre
Publikováno v:
Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences. 62(2)
Of 19 patients with advanced transitional bladder cancer (T2-T4, N0-N+, M0) who received two or three cycles of pre-emptive MVC (Methotrexate, Vinblastine, Cisplatin), pathological partial (PR) and complete (CR) remissions were observed in 67% (50% a
Autor:
Paolo Giunta, Carlo Patriarca, L. Zanitzer, M. DiPasquale, G. Ordesi, G. Gazzano, R. Macchi, P. Corrada, Franco Bergamaschi, B. Campo
Publikováno v:
Urology. 68:143
Publikováno v:
Urologia Journal. 59:78-79
Benign prostatic hypertrophy and inguinal hernia are frequently associated. 59 patients underwent transvesical prostatic adenomectomy and simultaneous pre-peritoneal hernioplasty by Nyhus' technique. Results lead the Authors to consider this techniqu
Publikováno v:
Urologia Journal. 59:151-152
The authors report preliminary results of a study performed on six patients with by advanced, hormone-refractory prostate cancer. These patients were treated by estramustine phosphate (10 mg/kg) and methotrexate (60 mg/mq). Low toxicity allows the us
Publikováno v:
Urologia Journal. 54:737-741
Publikováno v:
Urologia Journal. 51:834-837